News Roundup
- Tornado Tears Through Pfizer's N.C. Site, Threatening Crucial Drug Supplies: The impact to the manufacturing plant — and its ability to continue producing medicines — is not yet clear, according to Mittal Sutaria, a senior vice president of pharmacy contracts at Vizient, which provides contracting for medications to hospitals. The New York Times
- Drug Shortages Near an All-Time High, Leading to Rationing: That added "insult to injury," said Eric Tichy, a supply chain division chair at the Mayo Clinic and the board chairman of the End Drug Shortages Alliance. The New York Times
- Stronger: The 2022 Vizient Connections Summit Report: The 2022 Vizient Connections Summit brought more than 3,900 attendees together who explored and discussed many of the most pressing issues facing the industry following the worst of the pandemic. American Journal of Medical Quality
- Drug Shortages Lead to Higher Prices, Trouble Filling Prescriptions: Data showed a 16.6% increase in the price of drugs in shortage, driven mostly by an increase in the price of generics. Healthcare Finance
- Report: Hospital Capacity Challenges to Drive Expansion Of At-Home Care: The report — Sg2's 2023 Impact of Change Forecast — found that hospital capacity challenges will be severely tested, driven by higher patient-acuity levels and staffing shortages. Home Health Care News
- Lilly Results Add to Buzz Around Weight Loss Drugs: The results from the Phase 2 trials are adding to the buzz surrounding so-called GLP-1 treatments that act like hormones to cut individuals' food intake and are expected to become a $30 billion market by 2030. AXIOS
Blogs You May Have Missed
- New Data Point to Early Intervention for Atrial Fibrillation Patients
- Optimizing Healthcare Network Referrals Through "Blended Family" Approach
- Using Contracting and Clinical Data Collaboratively to Gain Clinical and Executive Support
- Your Technology Strategy is a C-suite Imperative
- Semaglutide: Weighing the Pros and Cons for Use in Pediatrics